Status:
COMPLETED
Adipokines as Predictors of Foot Function, Pain, and Disability in Patients With Rheumatoid Arthritis
Lead Sponsor:
King Saud University
Conditions:
Rheumatoid Arthritis
Healthy Control
Eligibility:
All Genders
35-60 years
Brief Summary
Significant increase in the levels of serum adiponectin, ADA, and hsCRP was reported in all RA patients compared to controls. Compared to patients with early RA, the increase in these markers signifi...
Detailed Description
The present study attempts to evaluate the efficacy of adiponectin, ADA, and foot bone mineral density (fBMD) as predictors of the disease progression in patients with rheumatoid arthritis. A total of...
Eligibility Criteria
Inclusion
- patients who diagnosed with Rheumatoid arthritis according to American Rheumatology Association criteria and radiographic analysis for at least 10 years previously were randomly involved in this study
- Not receiving any drugs affecting the data obtained
- had Normal daily diets
Exclusion
- Subjects with obvious ischemic heart disease (angina, myocardial infarction, and lead electrocardiogram abnormalities),
- HCV, HBV, chronic liver and kidney diseases, hypothyroidism.
- Drugs (diuretics; oral contraceptives).
Key Trial Info
Start Date :
February 20 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2015
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04036669
Start Date
February 20 2014
End Date
May 30 2015
Last Update
July 30 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.